Interpace Biosciences, Inc.
Interpace Biosciences, Inc. (IDXG) Stock Overview
Explore Interpace Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
8.7M
P/E Ratio
0.35
EPS (TTM)
$-0.66
ROE
4.85%
IDXG Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Interpace Biosciences, Inc. (IDXG) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 66.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.39.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.35 and a market capitalization of 8.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.